---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-326034"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T10:08:40.054453+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ORIC Pharmaceuticals appoints Angie You to board, Carl Gordon resigns

## Summary
- Carl Gordon, Ph.D., CFA, resigned as director voluntarily, no disagreement with board.
- Angie You, Ph.D., appointed as Class II director, term expires at 2022 annual meeting.
- You is CEO of Amunix Pharmaceuticals; previously chief business officer at Sierra Oncology and Aragon.
- She receives annual cash retainer of $35,000, committee fees, and stock option for 33,250 shares.
- No reportable transactions under Item 404(a) between You and ORIC.

## SEC filing metadata
- accession: 0001193125-21-326034
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/d241352d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-326034
- JSON: https://secwatch.observer/filing/0001193125-21-326034.json
- Plain text: https://secwatch.observer/filing/0001193125-21-326034.txt

## Key facts
- Executive change
  Carl Gordon resigned as director at Oric Pharmaceuticals, Inc..
  - Action: resigned
  - Role: director
  source text: On November 9, 2021, Carl Gordon, Ph.D., C.F.A. submitted his resignation as a director of ORIC Pharmaceuticals, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm
- Executive change
  Angie You was appointed as director at Oric Pharmaceuticals, Inc..
  - Action: appointed
  - Role: director
  source text: On November 9, 2021, the Board appointed Angie You, Ph.D. to serve as a Class II director, with a term expiring at the Company’s 2022 annual meeting of stockholders, as well as serve as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.